The event will showcase the Commission’s work to strengthen Europe's radioisotopes ecosystem and provide an opportunity to discuss related issues with public authorities, scientists, healthcare professionals, and industry from Luxembourg and the greater region.
The EU occupies a globally leading position in the production of medical radioisotopes, thanks to its research infrastructure, industrial expertise and strong clinical ecosystem. Hospitals across Europe perform 10 million nuclear medicine procedures a year, mostly for diagnostic imaging in oncology, cardiology and neurology. Furthermore, targeted radionuclide therapies and theranostics are increasingly important for cancer treatment.
Moderation: Angèle Scibilia
Information and Communication Officer, European Commission Representation in Luxembourg
- Welcoming remarks – Angèle Scibilia
Information and Communication Officer, European Commission Representation in Luxembourg
- Nuclear and Health: Are they related?”, keynote by Michael Huebel, Director-General, Euratom Supply Agency, Acting Deputy Director-General, Directorate-General for Energy
- “Nuclear Medicine Imaging and Treating (theranostics) – Benefits, challenges and opportunities in Luxembourg” - Dr. Olivier Schaeffer, Head of Nuclear Medicine Department, Centre Hospitalier de Luxembourg
- Europe’s Beating Cancer Plan – Matthias Schuppe, Head of Unit (acting) - Cancer, Health in all policies, DG SANTE, European Commission
- European Radioisotope Valley Initiative (ERVI) – Georgi Simeonov, SAMIRA Team Leader, Radiation protection and nuclear safety Unit, DG Energy, European Commission
- Securing the Supply of Medical Radioisotopes: The Role of the Euratom Supply Agency – Stefano Ciccarello, Head of Unit, Euratom Supply Agency
- Radiation Protection in Luxembourg - Alexandra Karoussou Schreiner, Ministry of Health and Social Security
- Q&A and discussion
- Concluding remarks – Jan Panek, Director Nuclear Energy, Safety and ITER, DG Energy, European Commission
